In summing up, d-MAPPS augmented T cell-driven immune response to murine mammary carcinoma by enhancing DC-based generation of Th1 and Th17 cells and by increasing cytotoxicity of CD8+ CTLs in CXCL16- and IL-27-dependent manner. Here, CD8A is linked to breast carcinoma.